​

Rallybio (RLYB) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Rallybio Revenue Highlights

0

Latest Revenue (Q)

$299.00K

Rallybio Revenue by Period

Rallybio Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Rallybio generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Rallybio Revenue by Quarter

DateRevenueChange
2024-09-30$299.00K-
2024-06-30$299.00K100.00%
2024-03-31--100.00%
2023-12-31$228.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Rallybio generated $299.00K in revenue during Q3 2024, up 0.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Rallybio Revenue Breakdown

Rallybio Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24
Collaboration And License Revenue$299.00K

Rallybio's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Collaboration And License Revenue (100.00%).

Rallybio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MOLNMolecular Partners$7.04M$2.74M
IPSCCentury Therapeutics$2.23M$791.00K
MNOVMediciNova$1.00M-
OPTOpthea$108.41K$61.27K
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
ANTXAN2 Therapeutics--
PHVSPharvaris--
RLYBRallybio-$299.00K
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
PEPGPepGen--

RLYB Revenue FAQ

What is Rallybio’s yearly revenue?

Rallybio's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RLYB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Rallybio’s quarterly revenue?

Rallybio's quarterly revenue for Q3 2024 was $299K, a 0% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $299K, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). RLYB's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Rallybio’s revenue growth rate?

Rallybio's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.